Oncolytics Biotech Inc.
ONCYOncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
Drugs in Pipeline
7
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 14, 2026
6wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
Carboplatin
Carcinoma, Squamous Cell of the Head and Neck
REOLYSIN
Metastatic or Recurrent Squamous Cell Carcinoma of the Lung
REOLYSIN®
Carcinoma, Non-small Cell Lung
Pelareorep
Anal Cancer Metastatic
Paclitaxel
Metastatic Melanoma
Gemcitabine
Metastatic Pancreatic Adenocarcinoma
FOLFIRI
Ras-mutated Metastatic Colorectal Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Carboplatin | Phase 3 | Carcinoma, Squamous Cell of the Head and Neck | - | - |
REOLYSIN | Phase 3 | Metastatic or Recurrent Squamous Cell Carcinoma of the Lung | - | - |
REOLYSIN® | Phase 2 | Carcinoma, Non-small Cell Lung | - | - |
Pelareorep | Phase 2 | Anal Cancer Metastatic | - | - |
Paclitaxel | Phase 2 | Metastatic Melanoma | - | - |
Gemcitabine | Phase 2 | Metastatic Pancreatic Adenocarcinoma | - | - |
FOLFIRI | Phase 2 | Ras-mutated Metastatic Colorectal Cancer | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Oncolytics Biotech Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in Oncolytics Biotech Inc.'s (ONCY) pipeline across Phase 3, Phase 2. Its lead program is Carboplatin (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Oncolytics Biotech Inc.'s next FDA catalyst?→
Oncolytics Biotech Inc.'s (ONCY) next tracked catalyst is a Earnings expected August 14, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ONCY biotech catalysts?→
Add ONCY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Oncolytics Biotech Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.